|
|
| | Quiflapon Basic information |
| Product Name: | Quiflapon | | Synonyms: | Quiflapon;MK 0591;3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylMethoxy)-1H-indol-2-yl)-2,2-diMethylpropanoic acid;1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)Methyl]-3-[(1,1-diMethylethyl)thio]-α,α-diMethyl-5-(2-quinolinylMethoxy)-;MK 591(Quiflapon);1-[(4-Chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-alpha,alpha-dimethyl-5-(2-quinolinylmethoxy)-1H-indole-2-propanoic acid;MK-0591 (Quiflapon);3-(3-(tert-Butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylp | | CAS: | 136668-42-3 | | MF: | C34H35ClN2O3S | | MW: | 587.17 | | EINECS: | | | Product Categories: | | | Mol File: | 136668-42-3.mol |  |
| | Quiflapon Chemical Properties |
| Boiling point | 751.3±60.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | solubility | Soluble in DMSO | | form | Powder | | pka | 4.70±0.10(Predicted) |
| | Quiflapon Usage And Synthesis |
| Uses | Anti-asthmatic; suppressant (inflammatory
bowel disease). | | target | FLAP |
| | Quiflapon Preparation Products And Raw materials |
|